Related references
Note: Only part of the references are listed.Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells
Qiang Wang et al.
CELL RESEARCH (2018)
Rapid steroid hormone actions via membrane receptors
Nofrat Schwartz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate
Frederik Holst
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression
Clemence Chamard-Jovenin et al.
BMC SYSTEMS BIOLOGY (2015)
Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer
Savas D. Soysal et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
ERα36-Another piece of the estrogen puzzle
Kamil Soltysik et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2015)
A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation
Saori Tomita et al.
NATURE COMMUNICATIONS (2015)
Expression and Localization of Estrogen Receptor in Human Breast Cancer and Its Clinical Significance
Lv Li et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells
Hao Deng et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
Hao Deng et al.
PLOS ONE (2014)
Role of ERα36 in membrane-associated signaling by estrogen
Reyhaan A. Chaudhri et al.
STEROIDS (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
Ching-Hung Lin et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells
Guangliang Li et al.
MOLECULAR ONCOLOGY (2013)
Prognostic Significance of ESR1 Amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 Polymorphisms in Breast Cancer Patients
Aleksandra Markiewicz et al.
PLOS ONE (2013)
ESR1 Amplification in Breast Cancer by Optimized RNase FISH: Frequent but Low-Level and Heterogeneous
Cathy B. Moelans et al.
PLOS ONE (2013)
Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-α36 (ERα36)
Reyhaan A. Chaudhri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Gene amplification of ESR1 in breast cancersufact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study
Akishi Ooi et al.
JOURNAL OF PATHOLOGY (2012)
Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction
Angelina Wallacides et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry
Anne-Vibeke Laenkholm et al.
MOLECULAR ONCOLOGY (2012)
Prognostic Significance of TOP2A Gene Dosage in HER-2-Negative Breast Cancer
Anna J. Zaczek et al.
ONCOLOGIST (2012)
Estrogen-independent effects of ER-α36 in ER-negative breast cancer
Jing Zhang et al.
STEROIDS (2012)
let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer
Yingchun Zhao et al.
MOLECULAR MEDICINE (2011)
A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells
X. T. Zhang et al.
ONCOGENE (2011)
ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study
Cathy B. Moelans et al.
CELLULAR ONCOLOGY (2011)
Molecularly targeted endocrine therapies for breast cancer
L. Orlando et al.
CANCER TREATMENT REVIEWS (2010)
Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples
Anna Zaczek et al.
CLINICAL BIOCHEMISTRY (2010)
Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients
Saori Tomita et al.
CANCER SCIENCE (2009)
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
Liang Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions
A. Lebeau et al.
JOURNAL OF PATHOLOGY (2008)
Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer
Frederik Holst et al.
NATURE GENETICS (2007)
A variant of estrogen receptor-α, hER-α36:: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling
ZY Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66
ZY Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Genomic variants in exons and introns: identifying the splicing spoilers
F Pagani et al.
NATURE REVIEWS GENETICS (2004)
Share Paper
